The role of mitogen-activated protein kinases (MAPKs) in regulation of inflammation is well known. MAPK family is activated by various stimuli and involved in transmitting extracellular signals to nucleus leading to gene regulation. Inflammation is primary defensive response of host against microbes. Controlled inflammation is helpful and indispensable for host defense. However, uncontrolled inflammatory response leads to various inflammatory diseases and cancer. Persistent inflammation leads to cell proliferation and survival that plays crucial role in tumorigenesis. In this review, we recapitulate the recent knowledge of MAPK signaling and its roles in inflammation-associated carcinogenesis.
INTRODUCTION
The innate immune system of mammals recognizes microbial infection and plays its role in elimination of microbes. Inflammation is primary protective response of host to eradicate destructive stimuli and repair injured tissue (1) . Inflammation is characterized by five fundamental symptoms: heat, redness, pain, swelling, and loss of tissue function (2) . Dendritic cells (DCs) and macrophages are the key player in innate immunity. In addition, endothelial cells, epithelial cells, and fibroblasts also take part in innate immunity. Controlled inflammatory response is indispensable and protects against destructive stimuli. However, deregulated inflammation is injurious because it leads to different diseases such as rheumatoid arthritis, atopic dermatitis, septic shock and cancer (1) Activated AP-1 and NF-κB is responsible for production of pro-inflammatory cytokines and chemokines (13) . The activation of MAPKs and NF-κB is tightly controlled by phosphorylation and ubiquitination and results in production of tumor necrosis factor (TNF)-α and interleukins (ILs) (14) .
TNF-α is recognized as a pro-or anti-tumorigenic protein.
TNF-α also promotes the production of inflammatory mediators including cyclooxygenase-2 (COX-2), IL-6, IL-8, and TNF-α and results in tumorigenesis through MAPK and NF-κB signaling cascade (15, 16) .
Inflammation plays important role in pathogenesis of diverse types of malignancies (17, 18) . Different stimulators including growth factors, stress, chemokines, cytokines and reactive oxygen species (ROS) result in activation of MAPK signaling pathways (19) . MAPK pathways are the key regulator in the activation of various pro-inflammatory cytokines in different cell types, including dendritic cells, macrophages, epithelial cells, and T cells (18) .
Cancer is essentially a disease of failure in tissue growth regulation (17) . The feature of caner is unregulated proliferation of cells (17) . Cancer cells can subvert c-Jun amino-terminal kinases (JNKs), ERKs and p38 MAPK pathways to facilitate proliferation, survival, and invasion (17) . Over-activation of ERK1 and ERK2 MAPKs has been associated with tumors (17, 20) . In addition, deregulations of JNK and p38 MAPK pathways are also related with cancer developments (17, 20) . As MAPKs have key roles in inflammation and cancer, it has been focused and shown by different scientists that targeting MAPK inhibition is beneficial for cancer therapy (17, 21) .
Mitogen-activated Protein Kinases
MAPKs were originally termed as extracellular signal- 
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JNK MAPKs and Cancer Development
JNKs were initially known as stress-activated kinases 
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Four p38 isoforms are identified in mammals: p38α, p38β, p38γ, and p38δ. Generally most of the tissues express p38α and p38β isoforms, however, p38γ and p38δ isoforms are expressed by skin, kidney and muscle cells (55) . The stress and inflammatory cytokines activate the p38 isoforms in mammalian cells (56) . Upon stimulation, p38 is phosphorylated by MKK3 and MKK6, which are controlled by MTK1 and ASK1 (57, 58) . Activated p38 results in phosphorylation of various cellular targets including cytosolic phospholipase A2, the microtubuleassociated protein Tau, and the transcription factors MEF2A, Sap-1, Elk-1, ATF1, ATF2, NF-κB, p53, and Ets-1. The p38 is also responsible for activation of some MKs, which includes MSK1, MSK2 and MNK1 (38) . The p38 is a critical regulator in inflammatory responses and cell proliferation (59) . The specific function of p38 MAPK is dependent on the cell type and also on the external stimulus (60) . The p38 MAPK play a key role in breast, liver, prostate, bladder and lung cancer (60) . The p38 MAPK has been reported to The p38α is also involved in up-regulation of heat shock protein 25 expression, which inhibits ROS accumulation (64, 65) . p21 is also called as cyclin-dependent kinase inhibitor 1 which binds to and inhibits the activity of cyclin and results in cell growth arrest. Inhibition of p38 results in enhanced p21 gene transcription in rat chondrosarcoma (66) . Pharmacological inhibition of p38 MAPK has been shown to reduce cell proliferation in rat chondrosarcoma (66) . In addition, in prostate cancer patients, the percentages of cells that were immunoreactive for p-ATF-2 or p-Elk-1 (downstream components of p38) were higher than in normal. It has been shown that inhibition of p38 might be helpful in the treatment of prostate cancer (67) .
Inflammation and Caner Development
Various epidemiological studies have shown that chronic inflammation, triggered by microbial infection and autoimmune diseases, is involved in the increased risk of tumorigenesis (21, 68) . In human chronic Salmonella typhi infection is allied with gallbladder cancer (69) . Chronic inflammation by Helicobacter pylori infection is associated with development of gastric cancer (70) . 
Conclusion and Perspective
Roles of MAPKs in inflammation and host protection against microbial infection have been well characterized. will help in the treatment of inflammatory diseases and cancer. MAPK inhibitors might be combined with conventional therapies of cancer to improve their efficacy.
